OLINK Proteomics Services
Targeted Protein Screening for Biomarker Discovery
ImmunoDiagnostics provides protein biomarker screening using Olink Proteomics Panels. Our advanced proteomics services enable highly sensitive and multiplex protein biomarker profiling for translational research, clinical studies, and biomarker discovery, powered by Olink's proprietary Proximity Extension Assay (PEA) technology.
Why Protein Biomarkers?
✓ Biomarkers for early diagnosis, prognosis, patient stratification, or monitoring treatment response are in increasing demand, with a growing focus on personalized medical treatment.
✓ Protein biomarkers offer a significantly higher degree of differentiated information compared to genomic biomarkers.
✓ Proteins represent direct functionality, making them essential in understanding disease pathology and associated biological processes.
✓ Targeted protein screening by Olink panels offers a unique way of investigating a selected part of the proteome in the search for disease-specific biomarkers, within multiple areas such as immunology, cardiovascular disease, neurology, and oncology.
Our Platform Portfolio
Olink® Reveal
Accessible proteomics for exploratory research
A streamlined solution designed to make proteomics accessible to a broader range of researchers. With the capacity to detect over 1,000 biomarkers, including more than 500 closely linked to inflammation, it is perfect for protein biomarker screening in exploratory research, delivering reliable data without the complexity.
Olink® Explore HT
Ultra-high-throughput proteomics
This solution enables biomarker detection without cross-reactivity and delivers high-quality data on a single platform. With the capacity to detect over 5,000 biomarkers, it is ideal for large-scale biomarker discovery studies requiring maximum proteome coverage.